Factors associated with treatment resumption and long-term outcomes after ICU discharge in patients with hematological malignancies
Ondine Messéant, Mathilde Guégan, Benoît Painvin, Adel Maamar, Jean-Baptiste Mear, Jean Reignier, Emmanuel Canet, Jean-Marc Tadié, Soraya Benguerfi · 2026
Read Factors associated with treatment resumption and long-term outcomes after ICU discharge in patients with hematological malignancies by Ondine Messéant, Mathilde Guégan, Benoît Painvin, Adel Maamar, Jean-Baptiste Mear, Jean Reignier, Emmanuel Canet, Jean-Marc Tadié, Soraya Benguerfi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13598578.txt.
Description
Ondine Messéant and eight co-authors published a critical care study in twenty twenty-six on what happens to blood cancer patients after intensive care. Surviving the ICU is not the end: post-intensive care problems can block the cancer treatment that survival was for. The team followed two hundred fifty-two patients admitted between twenty fourteen and twenty nineteen.
About sixty-eight percent left the ICU alive, and functional status had clearly worsened during the stay. Of those still needing cancer therapy, eighty-nine percent managed to resume it, though a fifth needed modified regimens. Heart and vessel disease independently lowered the odds of restarting treatment. Five-year survival was assessed alongside. The paper quantifies both the damage and the encouraging return to therapy.
Catalog record
| CREATOR | Ondine Messéant, Mathilde Guégan, Benoît Painvin, Adel Maamar, Jean-Baptiste Mear, Jean Reignier, Emmanuel Canet, Jean-Marc Tadié, Soraya Benguerfi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |